ALX Oncology Holdings Inc.
ALXO
$2.11
-$0.07-3.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 26.56M | 27.98M | 26.09M | 25.25M | 26.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 118.47M | 136.53M | 142.47M | 159.88M | 180.59M |
| Operating Income | -118.47M | -136.53M | -142.47M | -159.88M | -180.59M |
| Income Before Tax | -116.57M | -130.02M | -134.85M | -151.16M | -171.44M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -116.57 | -130.02 | -134.85 | -151.16 | -171.44 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -116.57M | -130.02M | -134.85M | -151.16M | -171.44M |
| EBIT | -118.47M | -136.53M | -142.47M | -159.88M | -180.59M |
| EBITDA | -117.63M | -135.66M | -141.60M | -159.01M | -179.74M |
| EPS Basic | -2.20 | -2.47 | -2.61 | -2.98 | -3.64 |
| Normalized Basic EPS | -1.34 | -1.54 | -1.63 | -1.86 | -2.27 |
| EPS Diluted | -2.20 | -2.47 | -2.61 | -2.98 | -3.64 |
| Normalized Diluted EPS | -1.34 | -1.54 | -1.63 | -1.86 | -2.27 |
| Average Basic Shares Outstanding | 212.30M | 210.69M | 207.45M | 203.64M | 192.10M |
| Average Diluted Shares Outstanding | 212.30M | 210.69M | 207.45M | 203.64M | 192.10M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |